Loyola University
Open enrollment across a mixed-phase pipeline
According to ClinicalTrials.gov-derived indexes, Loyola University sits in the top decile of US sponsors by registered trial count (#256 of 15,742 sponsors by registered trial count).
Loyola University: 92 sponsored US clinical trials, 12 recruiting.
Loyola University sponsors 92 registered US clinical trials on ClinicalTrials.gov, 12 of them currently recruiting, and 59 completed. 25 of these trials are in Phase 3-4 (later-stage) and 22 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Diabetes, with 3 trials.
Top-decile sponsor footprint
Loyola University ranks in the top decile of sponsors by registered trial count (#256 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
59 of 73 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (80.8%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
92 total, page 2 of 2
Can Vitamin D3 Improve Cognitive Function in Individuals With Type 2 Diabetes? (THINK-D)
NCT02416193
Port Size and Post-Operative Pain Perception by Patients
NCT02521987
Topical Anesthetic Use In Pessary Management
NCT02380742
Safety, Feasibility and Efficacy of Vitamin D Supplementation in Women With Metastatic Breast Cancer (SAFE-D)
NCT02186015
Mirabegron and Urinary Urgency Incontinence
NCT02495389
Evaluation of Gadoterate in Patients With Renal Dysfunction
NCT02382380
Acupuncture for Female IC/PBSyndrome and Its Effect on the Urinary Microbiome: A Randomized Controlled Trial
NCT02232282
Guided IMagery and Patient Satisfaction (GIMPS) Following Urogynecological Surgery
NCT02165280
Efficacy of Oral Antibiotic Therapy Compared to Intravenous Antibiotic Therapy for Osteomyelitis
NCT02168816
Precise Transvaginal Tape Placement Trial
NCT02101489
Sunshine 2 Study for Women With Diabetes
NCT01904032
Ultrasound Guided Posterior Sacroiliac Ligament Corticosteroid Injection in Pregnancy-Related Pelvic Girdle Pain
NCT02044991
Gestational Weight Gain and the Electronic Medical Record
NCT01987141
Sublingual Fentanyl and Procedural Burn Pain
NCT02241486
Compression Stocking Use in Shoulder Arthroscopy in Beach Chair
NCT01996813
Bacterial Genomic Sequencing in Overactive Bladder
NCT01642277
Incontinence & Intimate Partners: Assessing the Contribution of Treatment
NCT01559389
Surgical Pain Control With Ropivacaine by Atomized Delivery
NCT01480089
Lateral Canthal Rhytides With Medium Depth Chemical Peel With or Without Pretreatment With Botulinum Toxin A
NCT01586819
Bendamustine, Wkly Bortezomib, Lenalidomide and Dexamethasone for Multiple Myeloma
NCT01484626
Cyclooxygenase-2-Inhibitor Combination Treatment for Bipolar Depression
NCT01479829
Post Operative Walking Enhancements for Recovery (POWER) Trial
NCT01254851
Umbilical Cord Transplantation for the Elderly Population
NCT01484470
Abdominal Colpopexy: Comparison of Endoscopic Surgical Strategies
NCT01124916
Vitamin D for Improving Metabolic Control and Depressive Symptoms
NCT01185574
Assessing Maternal Post-partum Pain With Suppositories
NCT01271855
Bladder Drainage During Labor: A Randomized Controlled Study of Obstetric Foley Therapy
NCT00959920
Cardiovascular Biomarkers and Quetiapine in Depression and Anxiety Patients
NCT00951483
Glargine Dosing in Hospitalized Patients With Type 2 Diabetes and Renal Insufficiency
NCT00911625
Temsirolimus for Relapsed/Refractory Hodgkin's Lymphoma
NCT00838955
A Pilot Study, Evaluating the Efficacy of Regulatory T-cell Suppression by Ontak in Metastatic Pancreatic Cancer
NCT00726037
CATHETER ANALGESIA TRIAL Phenazopyrdine vs. Placebo: a Randomized Controlled Trial
NCT00771173
Modeling the Epidemiologic Transition Study
NCT02925156
Study Of MK-0752 In Combination With Tamoxifen Or Letrozole to Treat Early Stage Breast Cancer
NCT00756717
Carboplatin, Paclitaxel, and Bevacizumab in Treating Patients With Locally Recurrent or Metastatic Breast Cancer
NCT00654836
A Pychoeducational Intervention for Women With Diabetes
NCT01185561
Validation of a Real-time Urodynamic Measure of Urinary Urgency
NCT00909428
Ripening Interventions: Prostaglandins vs EASI Catheter
NCT00383942
Autologous Transplant Using Dose-Escalated Total Body Irradiation & Cyclophosphamide & Palifermin for NHL
NCT03042585
Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Chronic Myelogenous Leukemia or Acute Leukemia
NCT00004905
Interleukin-2 in Treating Patients With Stage III or Stage IV Kidney Cancer
NCT00003126
Combination Chemotherapy and Bone Marrow Transplant in Treating Patients With Refractory or Recurrent Ovarian Cancer
NCT00002474
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 5 |
| Phase 2 | 17 |
| Phase 3 | 4 |
| Phase 4 | 21 |
What is open in the Loyola University pipeline
12 recruiting of 92 indexed (13% open); 59 completed (64%).
Phase mix: 25 late (III/IV) vs 22 early (I/II) (balanced across stages).
Top condition: Diabetes (3 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Loyola University: open-pipeline peers nationwide
Peers matched on 92 registered trials and 13% open enrollment, not the therapeutic-area sidebar.
Loyola University sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 92 trials (± recruiting share)
- Children's National Research Institute · 92 trials · 38% recruiting
- Drexel University · 92 trials · 16% recruiting
- National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) · 93 trials · 13% recruiting
- National Institute on Alcohol Abuse and Alcoholism (NIAAA) · 93 trials · 17% recruiting
Sponsors near 13% open enrollment (± trial volume)
- Food and Drug Administration (FDA) · 13% recruiting · 23 trials
- VA Greater Los Angeles Healthcare System · 13% recruiting · 23 trials
- Intermountain Health Care · 13% recruiting · 85 trials
- MetroHealth Medical Center · 13% recruiting · 76 trials
Related
What to do with this Loyola University page
92 registered trials is a research-attention snapshot, not an endorsement of Loyola University or any single study.
- 12 of Loyola University's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Diabetes is the condition Loyola University studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Diabetes trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. Loyola University pipeline card: 92 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.